Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs

[1]  A. Furlan,et al.  Ets‐1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment , 2008, Journal of cellular physiology.

[2]  Arthur Js.  MSK activation and physiological roles. , 2008 .

[3]  H. Tsubouchi,et al.  Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid. , 2008, Biochemical and biophysical research communications.

[4]  S. Strom,et al.  Hepatocyte growth factor signaling pathway inhibits cholesterol 7α‐hydroxylase and bile acid synthesis in human hepatocytes , 2007, Hepatology.

[5]  Gerhard Christofori,et al.  Distinct mechanisms of tumor invasion and metastasis. , 2007, Trends in molecular medicine.

[6]  P. Comoglio,et al.  The MET receptor tyrosine kinase in invasion and metastasis , 2007, Journal of cellular physiology.

[7]  A. Sadanandam,et al.  Chemokines in tumor angiogenesis and metastasis , 2007, Cancer and Metastasis Reviews.

[8]  C. Boyault,et al.  HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination , 2007, Oncogene.

[9]  P. Maroni,et al.  c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor–Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells , 2007, Molecular Cancer Research.

[10]  H. Yoshida,et al.  Involvement of an Autocrine Stromal Cell–Derived Factor-1/CXCR4 System on the Distant Metastasis of Human Oral Squamous Cell Carcinoma , 2007, Molecular Cancer Research.

[11]  Manel Esteller,et al.  The role of histone deacetylases (HDACs) in human cancer , 2007, Molecular oncology.

[12]  Xiaohe Yang,et al.  Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. , 2007, Biochimica et biophysica acta.

[13]  Xiuli Wang,et al.  Histone deacetylase inhibitor trichostatin a potentiates doxorubicin‐induced apoptosis by up‐regulating PTEN expression , 2007, Cancer.

[14]  M. Desiderio.  Hepatocyte growth factor in invasive growth of carcinomas , 2007, Cellular and Molecular Life Sciences.

[15]  H. Allgayer,et al.  Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression , 2007, Oncogene.

[16]  M. Simon,et al.  Hypoxia-inducible factors: central regulators of the tumor phenotype. , 2007, Current opinion in genetics & development.

[17]  Qing Jiang,et al.  Roles of Aurora Kinases in Mitosis and Tumorigenesis , 2007, Molecular Cancer Research.

[18]  Mark A. Brown,et al.  Epigenetic aberrations and cancer , 2006, Molecular Cancer.

[19]  P. Diest,et al.  Hypoxia-inducible factor-1α expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas , 2006, Oncogene.

[20]  Qingbo Xu,et al.  HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells , 2006, The Journal of cell biology.

[21]  P. Comoglio,et al.  The Met pathway: master switch and drug target in cancer progression , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  N. L. La Thangue,et al.  Histone deacetylase inhibitors: gathering pace. , 2006, Current opinion in pharmacology.

[23]  Toshikazu Nakamura,et al.  Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions , 2006, International journal of cancer.

[24]  H. Shim,et al.  Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. , 2006, Biochemical and biophysical research communications.

[25]  P. Maroni,et al.  HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB , 2006 .

[26]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[27]  T. Egelhoff,et al.  Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. , 2006, Cancer research.

[28]  P. Klatt,et al.  Regulation of the INK4a/ARF Locus by Histone Deacetylase Inhibitors* , 2005, Journal of Biological Chemistry.

[29]  Ping-Hui Tseng,et al.  Histone Acetylation-independent Effect of Histone Deacetylase Inhibitors on Akt through the Reshuffling of Protein Phosphatase 1 Complexes* , 2005, Journal of Biological Chemistry.

[30]  Huan Yang,et al.  The Akt/PKB pathway: molecular target for cancer drug discovery , 2005, Oncogene.

[31]  M. Locati,et al.  Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness. , 2005, Experimental cell research.

[32]  Michael Karin,et al.  IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy , 2005 .

[33]  T. Fojo,et al.  Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. , 2005, Cancer research.

[34]  T. Hagemann,et al.  Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1 , 2005, The Journal of Immunology.

[35]  S. Shankar,et al.  HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma , 2005, Oncogene.

[36]  M. Lazar,et al.  Coactivators and Corepressors of NF-κB in IκBα Gene Promoter* , 2005, Journal of Biological Chemistry.

[37]  J. Votaw,et al.  Silencing of CXCR4 blocks breast cancer metastasis. , 2005, Cancer research.

[38]  N. Colburn,et al.  Histone Deacetylase Inhibition Down-Regulates Cyclin D1 Transcription by Inhibiting Nuclear Factor-κB/p65 DNA Binding , 2005, Molecular Cancer Research.

[39]  Sandip K. Mishra,et al.  Potential Role of a Novel Transcriptional Coactivator PELP1 in Histone H1 Displacement in Cancer Cells , 2004, Cancer Research.

[40]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[41]  E. Galun,et al.  Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[43]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[44]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[45]  H. Beere.  `The stress of dying': the role of heat shock proteins in the regulation of apoptosis , 2004, Journal of Cell Science.

[46]  W. Friedrichs,et al.  NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  E. Wang,et al.  SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors , 2004, Molecular and Cellular Biology.

[48]  H. Band,et al.  Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells , 2004, Oncogene.

[49]  Yiling Lu,et al.  Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades* , 2003, Journal of Biological Chemistry.

[50]  Jürgen Dittmer,et al.  Molecular Cancer BioMed Central Review The Biology of the Ets1 Proto-Oncogene , 2003 .

[51]  L. Marton,et al.  A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  Yang Shi,et al.  Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway* , 2003, Journal of Biological Chemistry.

[53]  Wei‐Chien Huang,et al.  Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.

[54]  A. Wellstein,et al.  Estradiol rapidly activates Akt via the ErbB2 signaling pathway. , 2003, Molecular endocrinology.

[55]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[56]  M. Szyf,et al.  Regulation of DNA Methylation in Human Breast Cancer , 2002, The Journal of Biological Chemistry.

[57]  R. Toillon,et al.  Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling. , 2002, Experimental cell research.

[58]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[59]  R C Coombes,et al.  Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[61]  Shaomeng Wang,et al.  3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. , 2000, Journal of medicinal chemistry.

[62]  L. Tacchini,et al.  Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. , 2000, Experimental cell research.

[63]  L. Pleyer,et al.  Regulation of apoptosis , 2007 .

[64]  M. Pazin,et al.  What's Up and Down with Histone Deacetylation and Transcription? , 1997, Cell.

[65]  Minoru Yoshida,et al.  [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[66]  J. Arthur.  MSK activation and physiological roles. , 2008, Frontiers in bioscience : a journal and virtual library.

[67]  M. Tyers,et al.  Duration of Nuclear NF-kB Action Regulated by Reversible Acetylation , 2001 .

[68]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.